National Health Investors, Inc. (NYSE:NHI) issued an update on its FY17 earnings guidance on Wednesday morning. The company provided earnings per share guidance of $5.22-5.26 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.18.
National Health Investors, Inc. (NHI) traded down 0.62% during mid-day trading on Friday, hitting $78.63. The stock had a trading volume of 180,659 shares. National Health Investors, Inc. has a 52 week low of $66.31 and a 52 week high of $82.53. The firm has a market cap of $3.22 billion, a PE ratio of 20.19 and a beta of 0.56. The company’s 50 day moving average price is $77.28 and its 200 day moving average price is $75.17.
National Health Investors (NYSE:NHI) last posted its earnings results on Wednesday, August 9th. The real estate investment trust reported $0.93 EPS for the quarter, missing the Zacks’ consensus estimate of $1.29 by $0.36. National Health Investors had a net margin of 59.24% and a return on equity of 12.56%. The business had revenue of $69.84 million for the quarter, compared to analyst estimates of $67.68 million. During the same quarter last year, the business earned $1.22 earnings per share. National Health Investors’s revenue was up 14.1% on a year-over-year basis. Analysts anticipate that National Health Investors, Inc. will post $3.88 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, November 10th. Stockholders of record on Friday, September 29th will be issued a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a dividend yield of 4.83%. The ex-dividend date is Thursday, September 28th. National Health Investors’s dividend payout ratio is currently 97.69%.
NHI has been the topic of several recent research reports. BidaskClub upgraded National Health Investors from a sell rating to a hold rating in a report on Thursday. Zacks Investment Research raised shares of National Health Investors from a sell rating to a hold rating in a research report on Wednesday, August 9th. Mizuho reaffirmed a neutral rating on shares of National Health Investors in a research report on Wednesday, June 28th. Stifel Nicolaus boosted their target price on National Health Investors from $80.00 to $82.00 and gave the company a buy rating in a research report on Wednesday, June 21st. Finally, ValuEngine lowered National Health Investors from a buy rating to a hold rating in a research report on Tuesday, June 13th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $79.60.
COPYRIGHT VIOLATION WARNING: This story was published by BNB Daily and is the sole property of of BNB Daily. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/19/national-health-investors-inc-nysenhi-updates-fy17-earnings-guidance-updated.html.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.